These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1746538)

  • 1. Characterization of novel platelet and endothelial cell target antigens in a family with genetic susceptibility to autoimmunity.
    Hashemi S; Drouin J; Trudel E; Aye MT; Couture R; Page D; Ganz PR
    Am J Hematol; 1991 Dec; 38(4):293-303. PubMed ID: 1746538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-platelet antibodies associated with the Canale-Smith syndrome bind to the same platelet glycoprotein complexes as those of idiopathic thrombocytopenic purpura patients.
    Grodzicky T; Bussel JB; Elkon KB
    Clin Exp Immunol; 2002 Feb; 127(2):289-92. PubMed ID: 11876752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet autoantibodies in immune thrombocytopenic purpura.
    Beardsley DS; Ertem M
    Transfus Sci; 1998 Sep; 19(3):237-44. PubMed ID: 10351135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is immune thrombocytopenic purpura (ITP) due to natural antibodies specific to platelets?
    Souberbielle BE
    Eur J Haematol; 1996 Mar; 56(3):178-80. PubMed ID: 8598239
    [No Abstract]   [Full Text] [Related]  

  • 5. [Platelet antigens, antibodies and related clinical conditions].
    Muñiz Díaz E
    Sangre (Barc); 1991 Oct; 36(5):395-415. PubMed ID: 1840085
    [No Abstract]   [Full Text] [Related]  

  • 6. Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura.
    Yanabu M; Nomura S; Fukuroi T; Suzuki M; Kawakatsu T; Kido H; Yamaguchi K; Kokawa T; Yasunaga K
    Br J Haematol; 1993 Aug; 84(4):694-701. PubMed ID: 8217830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal cellular immune mechanisms associated with autoimmune thrombocytopenia.
    Semple JW; Freedman J
    Transfus Med Rev; 1995 Oct; 9(4):327-38. PubMed ID: 8541715
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet antibodies in childhood idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Am J Hematol; 1996 Apr; 51(4):328. PubMed ID: 8602636
    [No Abstract]   [Full Text] [Related]  

  • 10. Target antigens of anti-platelet antibodies in patients with steroid-resistant ITP of recent onset. Canadian Apheresis Study Group.
    Rock G; Buskard N; Leblond P; Shumak K; Sutton D; Hashemi S
    Int J Hematol; 1992 Dec; 56(3):225-32. PubMed ID: 1477335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal alloimmune thrombocytopenia due to an antibody against a labile component of human platelet antigen-3b (Bak b).
    Kataoka S; Kobayashi H; Chiba K; Nakamura M; Shinada S; Morita S; Lin M; Shibata Y
    Transfus Med; 2004 Dec; 14(6):419-23. PubMed ID: 15569236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serological investigation of patients with autoimmune thrombocytopenia.
    Kelton JG
    Thromb Haemost; 1995 Jul; 74(1):228-33. PubMed ID: 8578463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that rat xenoreactive antibodies recognize multiple protein antigens on guinea pig endothelial cells and platelets.
    Scherrer L; Leventhal JR; Matas AJ; Dalmasso AP
    Transplantation; 1994 Aug; 58(4):458-66. PubMed ID: 8073515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet antibodies and their correlation with clinical findings in childhood immune thrombocytopenic purpura.
    Yildirmak Y; Yanikkaya-Demirel G; Palanduz A; Kayaalp N
    Acta Haematol; 2005; 113(2):109-12. PubMed ID: 15802889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgG and IgM antibodies to platelet membrane glycoprotein antigens in acute childhood idiopathic thrombocytopenic purpura.
    Winiarski J
    Br J Haematol; 1989 Sep; 73(1):88-92. PubMed ID: 2803983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivity of autoantibodies from chronic ITP patients with recombinant glycoprotein IIIa peptides.
    Bowditch RD; Tani P; McMillan R
    Br J Haematol; 1995 Sep; 91(1):178-84. PubMed ID: 7577629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects.
    Porta C; Caporali R; Montecucco C
    Haematologica; 1999 Mar; 84(3):260-9. PubMed ID: 10189393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GMP140 (CD62) autoantibody in a patient with autoimmune thrombocytopenic purpura.
    Bierling P; Bettaieb A; Fromont P; Favrin M; Duedari N
    Br J Haematol; 1994 Jul; 87(3):631-3. PubMed ID: 7527649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cellular immunology associated with autoimmune thrombocytopenic purpura: an update.
    Semple JW; Lazarus AH; Freedman J
    Transfus Sci; 1998 Sep; 19(3):245-51. PubMed ID: 10351136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet immunology. ELISA for detection of platelet antibodies, platelet-specific antigens and platelet glycoproteins.
    Taaning E
    Dan Med Bull; 1992 Aug; 39(4):343-54. PubMed ID: 1382006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.